Cytosin-Arabinosid
Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)
The First Affiliated Hospital of Soochow UniversityPhase 3Active
BBB
76/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 67/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ETOPOSIDE Alice Mims | Phase 3 | BBB |
Idarubicine The First Affiliated Hospital of Soochow University | Phase 2 | BBB |
Cyclophosphamide Sumithira Vasu | Phase 3 | BBB |
Fludarabine Rutgers, The State University of New Jersey | Phase 3 | BBB |
DEXAMETHASONE Steven E. Coutre | Phase 2 | BBB |
View all 14 →
Same molecule, other indications
Cytosin-Arabinosid is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →